Pleurisy and bilateral pleural effusions after administration of atorvastatin
Journal of the Pan African Thoracic Society · 2020
DOI: 10.25259/jpats_12_2020 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Pan African Thoracic Society, 2020. Verfasst von Amsalu Bekele Binegdie und 2 weiteren Autor:innen. Die Arbeit nennt 9 Literaturangaben.
Abstract (Originalsprache)
Atorvastatin is a widely used cholesterol-lowering agent. Although generally safe and well tolerated, a number of drug side effects have been reported. We report only the second case of atorvastatin-induced pleural effusions, presenting as pleurisy, and the first case from Ethiopia. We believe our patient had this association based on the temporal onset of symptoms, the otherwise negative evaluation, and the resolution of findings once atorvastatin was discontinued. Clinicians need to consider this relationship when evaluating unexplained pleurisy and pleural effusions in patients taking atorvastatin.
Zitieren
APA
Binegdie, A. B., Sherman, C. B., & Schluger, N. W. (2020). Pleurisy and bilateral pleural effusions after administration of atorvastatin. Journal of the Pan African Thoracic Society. https://doi.org/10.25259/jpats_12_2020
Vancouver
Binegdie AB, Sherman CB, Schluger NW. Pleurisy and bilateral pleural effusions after administration of atorvastatin. Journal of the Pan African Thoracic Society. 2020. doi:10.25259/jpats_12_2020
BibTeX
@article{Binegdie2020,
author = {Binegdie, Amsalu Bekele and Sherman, Charles B. and Schluger, Neil W.},
title = {Pleurisy and bilateral pleural effusions after administration of atorvastatin},
journal = {Journal of the Pan African Thoracic Society},
year = {2020},
doi = {10.25259/jpats_12_2020}
}
EUVIMED